GlassScriptPhysician profile
Alexander Reiner
NPI 1861831497
$4,627.93
in general payments reported to CMS, 2019-2025
45 companies · $709 in 2025
The $709 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,354 · 2020: $251 · 2021: $137 · 2022: $274 · 2023: $954 · 2024: $949 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,611.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $780.03 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $470.41 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $346.23 | 2022-2025 | |
| Lilly USA, LLC | $339.32 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $333.33 | 2019-2025 | |
| Glaxosmithkline, LLC. | $209.82 | 2019-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Dexcom, INC. | $200.22 | 2022-2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $181.64 | 2019-2024 | Trintellix |
| Astellas Pharma US INC | $179.91 | 2019-2024 | Veozah |
| Merck Sharp & Dohme LLC | $135.72 | 2019-2025 | Dificid, Gardasil 9, Vaxelis |
| Amarin Pharma, INC. | $103.95 | 2019-2020 | |
| Ethicon US, LLC | $97.92 | 2023 | Stratafix |
| Otsuka America Pharmaceutical, INC. | $97.64 | 2023-2025 | Rexulti, Abilify Asimtufii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.18 | 2019-2025 | Xifaxan, Cycloset |
| Amgen INC. | $82.44 | 2019-2025 | Krystexxa |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Reiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.